Psoriasis Concept

subject area of

• 2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009  Journal Articles
• A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 Pandemic  Journal Articles
• A Review of Drug-Drug Interactions for Biologic Drugs Used in the Treatment of Psoriasis  Journal Articles
• A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections  Journal Articles
• A Useful Clinical Tool for Psoriasis  Journal Articles
• A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial  Journal Articles
• A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*  Journal Articles
• A systematic review of recent randomized controlled trials for palmoplantar pustulosis.  Journal Articles
• A trial of the Actiderm dermatological patch and topical corticosteroids in the treatment of psoriasis vulgaris. The Actiderm Multi-Center Study Group.  Journal Articles
• Acitretin Use in Dermatology  Journal Articles
• Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet  Journal Articles
• Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal Studies  Journal Articles
• Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil  Journal Articles
• Age affects drug survival rates of interleukin (IL)‐17 and IL‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study  Journal Articles
• Aloe vera-loaded natural rubber latex dressing as a potential complementary treatment for psoriasis  Journal Articles
• An Open Letter to Health Canada  Journal Articles
• An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis  Journal Articles
• An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab.  Journal Articles
• Association Between Parkinson’s Disease and Psoriasis: A Scoping Review  Journal Articles
• Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)  Journal Articles
• Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial  Journal Articles
• Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis  Journal Articles
• Biologic survival.  Journal Articles
• Biosimilars for psoriasis: clinical studies to determine similarity  Journal Articles
• Biosimilars for psoriasis: preclinical analytical assessment to determine similarity  Journal Articles
• Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice  Journal Articles
• Briakinumab  Journal Articles
• Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors  Journal Articles
• Canadian Guidelines for the Management of Plaque Psoriasis: Overview  Journal Articles
• Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys  Journal Articles
• Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers  Journal Articles
• Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study  Journal Articles
• Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway  Journal Articles
• Clinical practice guidelines for psoriasis: which ones are the best?  Journal Articles
• Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis  Journal Articles
• Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.  Journal Articles
• Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin  Journal Articles
• Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials  Journal Articles
• Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse)  Journal Articles
• Cytokine-Based Therapy in Psoriasis  Journal Articles
• Drug-Induced Lichenoid Dermatitis with Histopathologic Features of Mycosis Fungoides in a Patient with Psoriasis  Journal Articles
• Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study  Journal Articles
• Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis  Journal Articles
• Efficacy Outcomes in Patients Using Alefacept in the AWARE Study  Journal Articles
• Efficacy and Safety of Tripterygium wilfordii Hook F Versus Acitretin in Moderate to Severe Psoriasis Vulgaris  Journal Articles
• Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)  Journal Articles
• Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice  Journal Articles
• Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab  Journal Articles
• Granulocyte–macrophage colony‐stimulating factor ( GM ‐ CSF ) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐ GM ‐ CSF monoclonal antibody  Journal Articles
• Guselkumab dosing interval optimization in adult patients with psoriasis: A retrospective, multicenter case series  Journal Articles
• Immune Thrombocytopenia Associated with Efalizumab Therapy for Psoriasis  Journal Articles
• Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.  Journal Articles
• Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study  Journal Articles
• Incidence and prognosis of COVID‐19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study  Journal Articles
• Infliximab‐Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL‐23 Receptor Polymorphisms  Journal Articles
• Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab  Journal Articles
• Interleukin 17A: Toward a new understanding of psoriasis pathogenesis  Journal Articles
• Machine Learning Applications in Psoriasis Treatment: A Systematic Review  Journal Articles
• Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition  Journal Articles
• Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper  Journal Articles
• Management of adult generalized pustular psoriasis using biologics: A systematic review  Journal Articles
• Management of pediatric generalized pustular psoriasis using biologics: An evidence-based review  Journal Articles
• Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials  Journal Articles
• Modular pharmacology-based approach to identify hub genes and kernel pathways of taodan granules treated psoriasis  Journal Articles
• Morphea in patients with psoriasis treated with ustekinumab: a scoping review  Journal Articles
• Mycophenolate Mofetil (CellCept�) for Psoriasis: A Two-Center, Prospective, Open-Label Clinical Trial  Journal Articles
• Nail Psoriasis and Biologics  Journal Articles
• Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 Women  Journal Articles
• Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab  Journal Articles
• Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis  Journal Articles
• Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod‐induced psoriasis‐like inflammation  Journal Articles
• One-Year, Multicenter, Open-Label, Single-Arm Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Moderate-to-Severe Plaque Psoriasis in a Canadian Population  Journal Articles
• Our Choice: study protocol for a randomized controlled trial for optimal implementation of psoriasis treatment by the integration of Chinese and western medicine  Journal Articles
• Paradoxical, Cupping-Induced Localized Psoriasis: A Koebner Phenomenon  Journal Articles
• Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil  Journal Articles
• Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice  Journal Articles
• Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone  Journal Articles
• Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics  Journal Articles
• Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline.  Journal Articles
• Psoriasis Is Associated With Elevated Gut IL-1α and Intestinal Microbiome Alterations  Journal Articles
• Psoriasis in systemic lupus erythematosus: a single-center experience  Journal Articles
• Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy  Journal Articles
• Psoriasis patients’ preference for an aerosol foam topical formulation  Journal Articles
• Psoronychomycosis  Journal Articles
• Quality of Life and Body Region Affected by Psoriasis: A Systematic Review  Journal Articles
• Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study  Journal Articles
• Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 Therapies  Journal Articles
• Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial  Journal Articles
• Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)  Journal Articles
• Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study  Journal Articles
• Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials  Journal Articles
• Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study  Journal Articles
• Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis.  Journal Articles
• Skin erythema assessment techniques  Journal Articles
• Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks  Journal Articles
• Survival of the fittest  Journal Articles
• The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis  Journal Articles
• The Role of Antimalarials in the Exacerbation of Psoriasis  Journal Articles
• The Safety of Infliximab Infusions in the Community Setting  Journal Articles
• Think beyond the Skin  Journal Articles
• Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations  Journal Articles
• Topical calcipotriol in childhood psoriasis  Journal Articles
• Topical roflumilast for the treatment of psoriasis  Journal Articles
• Transitioning Between Brodalumab and Secukinumab in Moderate to Severe Psoriasis: An Early Look.  Journal Articles
• Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice  Journal Articles
• Treatment of severe facial psoriasis with adalimumab.  Journal Articles
• Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario, Canada  Journal Articles
• Trends in the Prevalence and Incidence of Psoriasis and Psoriatic Arthritis in Ontario, Canada: A Population‐Based Study  Journal Articles
• Under-Reporting of COVID-19 Infections in Psoriasis Patients on Biologics  Journal Articles
• Use of Calcipotriene Cream (Dovonex?? Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex??)  Journal Articles
• Use of Janus Kinase Inhibitor Treatment for Palmoplantar Pustulosis: An Evidence-Based Review  Journal Articles
• Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?  Journal Articles
• Water bath hyperthermia is a simple therapy for psoriasis and also stimulates skin tanning in response to sunlight  Journal Articles
• Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis  Journal Articles
• [Artículo traducido] Calidad de vida y región corporal afectada por la psoriasis: una revisión sistemática  Journal Articles